Phacolytic glaucoma other societal roles (such as driving and reading) as it reduces visual clarity. Phacolysis tends to be more frequently reported in underdeveloped countries because of the lack of resources necessary to treat such as condition. There are a variety of characteristics which indicate that an individual may have phacolytic glaucoma. Within older people, the lens of the eye may appear to be yellow and lose its transparency (becomes cloudy). Once the protein begins to seep into the lens, permanent damage to the lens may be caused as the precipitate in lens impairs vision. Another symptom includes the fading of visual
Minimally invasive glaucoma surgery to augment outflow to the suprachoroidal space in order to control intraocular pressure; it is indicated for the treatment of primary open-angle glaucoma. The stent is implanted through an ab interno approach and inserted into the supraciliary space (between the ciliary body and sclera), effectively creating a controlled cyclodialysis cleft, which is kept open by the device. The first clinical data on the device was presented in 2010 showed sustained IOP lowering and MIGS-like safety profile. This has been substantiated in subsequent studies in the combined setting with cataract surgery and as a stand-alone treatment for patients failing glaucoma topical